Treatment of Bulimia Nervosa in Patients with Comorbid Obesity

When bulimia nervosa occurs alongside obesity, both conditions require simultaneous clinical attention. Guideline-based recommendations address this specific combination.

Clinical Scenario

Bulimia nervosa with comorbid obesity — a presentation where weight management considerations intersect with eating disorder treatment, requiring an approach tailored to both conditions.

Treatment Approach (Partial Overview)

The protocol for this scenario incorporates an antiobesity medication for weight loss alongside standard bulimia nervosa treatment. The complete regimen, including specific agents and clinical guidance, is available in the full protocol.

Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.1097/YCO.0000000000000360

For patients with comorbid obesity, one guideline recommended the antiobesity medication orlistat (Australia and New Zealand).

View source ↗